P21

Cognitive Preclinical

Synthetic peptide derived from CNTF that promotes neurogenesis without the appetite-suppressing effects of the parent compound.

Key Data

Research Status
Preclinical
Half-Life
Unknown
Administration
Intranasal or subcutaneous
Typical Dosage
100-400 mcg

Mechanism of Action

Promotes neurogenesis and cognitive enhancement through CNTF-related pathways without systemic effects.

Reported Benefits

All information is presented for Research Use Only (RUO). Not medical advice.

← All Peptides Dosing Calculator Community Forum Home